SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tingting Xu, Xiaomin Ou, Chunying Shen, Chaosu Hu, Cetuximab in combination with chemoradiotherapy in the treatment of recurrent and/or metastatic nasopharyngeal carcinoma, Anti-Cancer Drugs, 2016, 27, 1, 66

    CrossRef

  2. 2
    Ji Hyun Chang, Yong Chan Ahn, Hyojung Park, Dongryul Oh, Jae Myoung Noh, Jong-Mu Sun, Myung-Ju Ahn, Keunchil Park, Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy, Head & Neck, 2016, 38, S1
  3. 3
    Michela Casanova, Enis Özyar, Catherine Patte, Daniel Orbach, Andrea Ferrari, Christine Veyrat-Follet, Hassan Errihani, Jianji Pan, Li Zhang, Liji Shen, Krzysztof J. Grzegorzewski, Ali Varan, International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents, Cancer Chemotherapy and Pharmacology, 2016, 77, 2, 289

    CrossRef

  4. 4
    Melvin L K Chua, Joseph T S Wee, Edwin P Hui, Anthony T C Chan, Nasopharyngeal carcinoma, The Lancet, 2016, 387, 10022, 1012

    CrossRef

  5. 5
    Yunbin Chen, Wang Ren, Dechun Zheng, Jing Zhong, Xiangyi Liu, Qiuyuan Yue, Meng Liu, Youping Xiao, Weibo Chen, Queenie Chan, Jianji Pan, Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients, Journal of Magnetic Resonance Imaging, 2015, 42, 5
  6. 6
    Ting Jin, Xiao-Zhong Chen, Jian-Jiang Liu, Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma, Oncology Letters, 2015,

    CrossRef

  7. 7
    T. Yoshizaki, S. Kondo, S. Murono, K. Endo, A. Tsuji, Y. Nakanishi, S. Nakanishi, H. Sugimoto, M. Hatano, T. Ueno, N. Wakisaka, Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma, Japanese Journal of Clinical Oncology, 2015, 45, 3, 244

    CrossRef

  8. 8
    Yaqi Song, Wanwei Wang, Guangzhou Tao, Xilie Zhou, Survival benefit of induction chemotherapy in treatment for locally advanced nasopharyngeal carcinoma – A time-to-event meta-analysis, Oral Oncology, 2015, 51, 8, 764

    CrossRef

  9. 9
    Jin Ho Song, Hong-Gyun Wu, Bhum Suk Keam, Jeong Hun Hah, Yong Chan Ahn, Dongryul Oh, Jae Myoung Noh, Hyo Jung Park, Chang Geol Lee, Ki Chang Keum, Jihye Cha, Kwan Ho Cho, Sung Ho Moon, Ji-Yoon Kim, Woong-Ki Chung, Young Taek Oh, Won Taek Kim, Moon-June Cho, Chul Seung Kay, Yeon-Sil Kim, The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-Institutional Retrospective Study Using Propensity Score Matching Analysis, Cancer Research and Treatment, 2015,

    CrossRef

  10. 10
    Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch: Radioimmunotherapy for oncological indications, OncoImmunology, 2014, 3, 9, e954929

    CrossRef